CharlesBradleyHareMD

PubMed

• 7 citations
  Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system.
  Christophe T Tchakoute, Soo-Yon Rhee, C Bradley Hare, Robert W Shafer, Kristin Sainani> ;Plos One. 2022 Jan 1
• 13 citations
  Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco
  J Carlo Hojilla, Julia L. Marcus, Michael J. Silverberg, C. Bradley Hare, Rachel Herbers, Leo B. Hurley, Derek D. Satre, Jonathan E. Volk> ;Clinical Infectious Diseases. 2020 Dec 17
• 19 citations
  Adverse childhood experiences, mental health, substance use, and HIV-related outcomes among persons with HIV.
  Kelly C. Young-Wolff, Varada Sarovar, Stacy Sterling, Amy Leibowitz, Brigid McCaw, Charles Bradley Hare, Michael J. Silverberg, Derek D. Satre> ;AIDS Care. 2019 Mar 19
• Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study.
  Silverberg, M. J.,Leyden, W. A.,Leibowitz, A.,Hare, C. B.,Jang, H. J.,Sterling, S.,Catz, S. L.,Parthasarathy, S.,Horberg, M. A.,Satre, D. D.> ;Addict Behav. 2018 Apr 17
• HIV Infection and Drug Resistance with Unsupervised Use of HIV Preexposure Prophylaxis.
  Volk, J. E.,Nguyen, D. P.,Hare, C. B.,Marcus, J. L.> ;AIDS Res. Hum. Retroviruses. 2017 Dec 22
• 211 citations
  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.
  Julia L. Marcus, Leo B. Hurley, Charles Bradley Hare, Dong Phuong Nguyen, Tony Phengrasamy, Michael J. Silverberg, Juliet E. Stoltey, Jonathan E. Volk> ;Journal of Acquired Immune Deficiency Syndromes. 2016 Dec 1
• Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco.
  John MD, Greene M, Hessol NA, Zepf R, Parrott AH, Foreman C, Bourgeois J, Gandhi M, Hare CB> ;J. Acquir. Immune Defic. Syndr.. 2016-08-15
• Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
  Marcus, J. L.,Volk, J. E.,Pinder, J.,Liu, A. Y.,Bacon, O.,Hare, C. B.,Cohen, S. E.> ;Curr HIV/AIDS Rep. 2016 Feb 24
• No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
  Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB> ;Clin. Infect. Dis.. 2015-11-15
• Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
  Volk JE, Marcus JL, Phengrasamy T, Hare CB> ;Clin. Infect. Dis.. 2015-06-01
• Leveraging A Rapid, Round-the-Clock HIV Testing System to Screen for Acute HIV Infection in a Large Urban Public Medical Center.
  Christopoulos, K. A., Zetola, N. M., Klausner, J. D., Haller, B., Louie, B., Hare, C. B., Pandori, M., Nassos, P., Roemer, M., Pilcher, C. D.> ;J Acquir Immune Defic Syndr. 2013 Feb 1
• The Effect of a "Universal Antiretroviral Therapy" Recommendation on HIV RNA Levels among HIV-Infected Patients Entering Care with a CD4 Count Greater than 500/μl in ...
  Geng, E. H., Hare, C. B., Kahn, J. O., Jain, V., Van Nunnery, T., Christopoulos, K., Deeks, S. G., Gandhi, M., Havlir, D. V.> ;Clin Infect Dis. 2012 Dec
• Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia.
  Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG> ;J. Acquir. Immune Defic. Syndr.. 2011-11-01
• The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical pra...
  Geng EH, Kahn JS, Chang OC, Hare CB, Christopoulos KA, Jones D, Petersen ML, Deeks SG, Havlir DV, Gandhi M> ;Clin. Infect. Dis.. 2011-11-01
• Mortality among antiretroviral-eligible patients in an urban public clinic.
  Dowdy DW, Geng EH, Christopoulos KA, Kahn JS, Hare CB, Wlodarczyk D, Havlir DV> ;J. Acquir. Immune Defic. Syndr.. 2011-08-01
• Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.
  Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havli...> ;Clin. Infect. Dis.. 2008-08-01
• Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007.
  Zetola NM, Grijalva CG, Gertler S, Hare CB, Kaplan B, Dowling T, Colfax G, Katz MH, Klausner JD> ;PLoS ONE. 2008-07-02
• Poverty, unstable housing, and HIV infection among women living in the United States.
  Riley ED, Gandhi M, Hare C, Cohen J, Hwang S> ;Curr HIV/AIDS Rep. 2007-12-01
• Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
  Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM> ;Clin. Infect. Dis.. 2006-03-01
• Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.
  Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M> ;J. Acquir. Immune Defic. Syndr.. 2006-01-01
• Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
  Hare CB, Vu MP, Grunfeld C, Lampiris HW> ;Clin. Infect. Dis.. 2002-11-15
• Patient Perspectives on the Experience of Being Newly Diagnosed with HIV in the Emergency Department/Urgent Care Clinic of a Public Hospital.
  Christopoulos, K. A.,Massey, A. D.,Lopez, A. M.,Hare, C. B.,Johnson, M. O.,Pilcher, C. D.,Fielding, H.,Dawson-Rose, C.> ;PLoS ONE. 2013
• Join now to see all